Skincare Ingredient Science and Derm Studies — 2026-10-15
Bemotrizinol (BEMT), the first new sunscreen active ingredient approved by the FDA in over 25 years, has officially hit U.S. store shelves this week. Meanwhile, a new systematic review highlights the efficacy of oral and topical peptides for skin aging, and Japanese media reports on new retinol formulations designed to minimize irritation.
Skincare Ingredient Science and Derm Studies — 2026-10-15
Top developments
Bemotrizinol (BEMT) Sunscreens Launch in the US
The first products containing bemotrizinol (BEMT) are now available in the United States, marking the first time a new sunscreen filter has been approved by the FDA in over two decades. The FDA finalized the addition of bemotrizinol to its OTC sunscreen monograph in June 2026, allowing concentrations up to 6%. This ingredient, long used in Europe and Asia, offers broad-spectrum UVA/UVB protection without the white cast or greasy residue associated with mineral filters. Major brands including La Roche-Posay and Ultra Violette are rolling out updated formulas featuring this "gamechanger" filter.
Systematic Review Confirms Peptide Efficacy for Skin Aging
A new systematic review and meta-analysis of randomized controlled trials published in Frontiers in Medicine confirms that both oral and topical peptides significantly improve skin aging markers such as wrinkles and elasticity. The study underscores the growing clinical evidence supporting peptide-based therapies as viable alternatives or complements to traditional actives like retinoids. This aligns with recent consumer trends where peptides are increasingly viewed as a gentle, effective option for collagen boosting.
New Retinol Formulations Target Irritation Reduction
Japanese cosmetics company Mission has launched a new retinol cream, "Mission Reti Cream," which claims to deliver retinol directly to the skin's deeper layers while minimizing surface irritation. The launch follows a broader industry push toward "gentler yet more powerful" formulas, with dermatologists noting that new encapsulation technologies are reducing the common side effects of vitamin A derivatives. In Korea, Lotte’s "Double Retinol Cream" also gained attention for showing wrinkle and elasticity improvements in just four weeks of use.
Local view
In South Korea, Cosinkorea reports that Cosmax Korea presented its "Skin Longevity" research and proprietary materials at the IFSCC Congress in Perth, highlighting the local industry's focus on scientific backing for anti-aging claims. Meanwhile, View.asiae notes that Volufiline is emerging as the next big ingredient keyword in K-beauty, following the trends of retinol and PDRN, as brands compete for "ingredient supremacy". In Japan, Sankei Shimbun covered the launch of Mission's new retinol technology, emphasizing the consumer demand for high-efficacy ingredients with lower irritation profiles.
Context & numbers
The global anti-wrinkle product market is projected to accelerate through 2035, driven by preventive skincare demand and clinical evidence for topical solutions. Bemotrizinol was approved for use at concentrations up to 6% in the US, a limit that matches many European standards but represents a new ceiling for American formulations. The FDA's decision process took approximately seven months from the proposed order in December 2025 to finalization in June 2026.
On the radar
- Bisoctrizole GRASE Determination: The FDA is expected to make a potential GRASE (Generally Recognized As Safe and Effective) determination for bisoctrizole, another modern UV filter, with updates anticipated in early 2026.
- Volufiline Trend: Watch for increased adoption of Volufiline in K-beauty and Western brands as it moves from niche to mainstream ingredient status.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
